Showing results (241-250 of 281) with videos related to
Sort By:
Pageof 29
JACC. Clinical Electrophysiology|February 4, 2025
Tricuspid Transcatheter Edge-to-Edge Repair in Patients With Transvalvular CIED Leads: The TRILUMINATE Pivotal TrialHursh Naik, Matthew J Price, Samir Kapadia, et al.American Heart Journal|June 5, 2017
Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trialFreddy Abnousi, Vandana Sundaram, Celina M Yong, et al.JACC. Cardiovascular Interventions|June 28, 2023
Expanding the Spectrum of TEER Suitability: Evidence From the EXPAND G4 Post Approval StudyJason H Rogers, Federico Asch, Paul Sorajja, et al.Journal of Thrombosis and Thrombolysis|November 18, 2015
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomesJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.European Heart Journal|June 5, 2025
Optical coherence tomography- vs angiography-guided coronary stent implantation in calcified lesions: the ILUMIEN IV trialZiad A Ali, Doosup Shin, Rajesh Vijayvergiya, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 7, 2023
Two-year results from Onyx ONE clear in patients with high bleeding risk on one-month DAPT with and without intracoronary imagingGabor G Toth, David E Kandzari, Ajay J Kirtane, et al.Circulation. Cardiovascular Interventions|January 21, 2026
Atrial Secondary Mitral Regurgitation Outcomes Following Mitral Transcatheter Edge-to-Edge Repair: Results From the EXPANDed StudiesMark J Ricciardi, Gagan Singh, Jason H Rogers, et al.Journal of the American College of Cardiology|September 11, 2010
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphateLaurent Bonello, Udaya S Tantry, Rossella Marcucci, et al.Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Coronary Stenting in High Bleeding Risk Patients With Small Coronary Arteries Followed by One-Month Dual Antiplatelet Therapy: Onyx ONE ClearRaúl Moreno, David E Kandzari, Ajay J Kirtane, et al.American Heart Journal|January 25, 2008
A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery diseaseGiuseppe G L Biondi-Zoccai, Marzia Lotrionte, Claudio Moretti, et al.Pageof 29